Biohaven Ltd. (BHVN) NEW YORK STOCK EXCHANGE INC.

$16.41 0.44 (2.76%)

Market Cap: $1.09B

As of 12/07/22 04:00 PM EST. Market closed.

(BHVN)

Biohaven Ltd. (BHVN) NEW YORK STOCK EXCHANGE INC.

$16.41 0.44 (2.76%)

Market Cap: $1.09B

As of 12/07/22 04:00 PM EST. Market closed.

Biohaven Pharmaceutical Holding Company Ltd. is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven's neuroinnovation portfolio includes FDA-approved NURTEC ODT (rimegepant) for the acute treatment of migraine and a ... read more

Biohaven Pharmaceutical Holding Company Ltd. is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven's neuroinnovation portfolio includes FDA-approved NURTEC ODT (rimegepant) for the acute treatment of migraine and a broad pipeline of late-stage product candidates across three distinct mechanistic platforms: CGRP receptor antagonism for the acute and preventive treatment of migraine; glutamate modulation for obsessive-compulsive disorder, Alzheimer's disease, and spinocerebellar ataxia; and MPO inhibition for multiple system atrophy and amyotrophic lateral sclerosis. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$7.85M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$7.85M
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$16.15
Previous Close
$15.97
Days Range
$15.55 - $16.62
52 week range
$5.54 - $17.86
Volume
578,325
Avg. Volume (30 days)
884,759
Market Cap
$1.09B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
68,160,979
Open
$16.15
Previous Close
$15.97
Days Range
$15.55 - $16.62
52 week range
$5.54 - $17.86
Volume
578,325
Avg. Volume (30 days)
884,759
Market Cap
$1.09B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
68,160,979

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIOHAVEN LTD
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Coric Vlad Chief Executive Officer Oct 31, 2022 Buy $15.97 25,800 411,995 1,543,394 Nov 01, 2022, 07:34 AM
Coric Vlad Chief Executive Officer Oct 28, 2022 Buy $14.82 100,000 1,482,420 109,565 Oct 31, 2022, 07:52 AM
Coric Vlad Chief Executive Officer Oct 28, 2022 Buy $14.87 41,930 623,352 1,517,594 Oct 31, 2022, 07:52 AM
Bailey Gregory Director Oct 25, 2022 Buy $10.50 200,000 2,100,000 1,507,971 Oct 26, 2022, 06:22 PM
Coric Vlad Chief Executive Officer Oct 25, 2022 Buy $10.50 853,380 8,960,490 1,475,664 Oct 26, 2022, 06:22 PM
CHILDS JOHN W Director Oct 25, 2022 Buy $10.50 3,900,000 40,950,000 5,691,251 Oct 26, 2022, 06:22 PM
Buten Matthew Chief Financial Officer Oct 25, 2022 Buy $10.50 142,857 1,499,999 166,653 Oct 26, 2022, 06:21 PM
GREGORY JULIA P Director Oct 25, 2022 Buy $10.50 9,523 99,992 25,665 Oct 26, 2022, 06:19 PM
HUGIN ROBERT J Director Oct 03, 2022 Option Exercise $7.50 12,959 97,193 12,959 Oct 12, 2022, 06:31 PM
Heffernan Michael Thomas Director Oct 03, 2022 Option Exercise $7.50 9,699 72,743 15,178 Oct 12, 2022, 06:31 PM
Coric Vlad Chief Executive Officer Oct 05, 2022 Buy $10.31 242,693 2,502,096 399,443 Oct 06, 2022, 07:20 PM
Coric Vlad Chief Executive Officer Oct 05, 2022 Buy $10.31 243,082 2,507,329 492,212 Oct 06, 2022, 07:20 PM
CHILDS JOHN W Director Oct 05, 2022 Buy $8.98 274,141 2,461,172 1,791,251 Oct 05, 2022, 09:44 PM
Heffernan Michael Thomas Director Oct 03, 2022 Option Exercise $7.50 5,507 41,303 19,370 Oct 05, 2022, 05:42 PM
Heffernan Michael Thomas Director Oct 03, 2022 Option Exercise $3.13 23,217 72,729 24,877 Oct 05, 2022, 05:42 PM
Gentile Kimberly SVP, Clinical Operations Oct 03, 2022 Option Exercise $7.00 37,492 262,444 95,969 Oct 05, 2022, 05:42 PM
Gentile Kimberly SVP, Clinical Operations Oct 03, 2022 Option Exercise $2.43 115,510 281,160 133,461 Oct 05, 2022, 05:42 PM
Mehta Kishan Director Oct 03, 2022 Option Exercise $7.00 11,716 82,012 22,662 Oct 05, 2022, 05:39 PM
Mehta Kishan Director Oct 03, 2022 Option Exercise $3.12 28,121 87,860 34,378 Oct 05, 2022, 05:39 PM
GREGORY JULIA P Director Oct 03, 2022 Option Exercise $7.50 11,975 89,813 16,142 Oct 05, 2022, 05:39 PM
GREGORY JULIA P Director Oct 03, 2022 Option Exercise $3.19 28,117 89,799 28,117 Oct 05, 2022, 05:39 PM
CHILDS JOHN W Director Oct 03, 2022 Option Exercise $7.50 5,507 41,303 1,522,110 Oct 05, 2022, 05:37 PM
CHILDS JOHN W Director Oct 03, 2022 Option Exercise $4.08 10,117 41,289 1,527,617 Oct 05, 2022, 05:37 PM
HUGIN ROBERT J Director Oct 03, 2022 Option Exercise $7.50 3,263 24,473 19,486 Oct 05, 2022, 05:37 PM
HUGIN ROBERT J Director Oct 03, 2022 Option Exercise $3.75 19,591 73,406 22,749 Oct 05, 2022, 05:37 PM
Buten Matthew Chief Financial Officer Oct 03, 2022 Option Exercise $7.50 11,042 82,815 23,796 Oct 05, 2022, 05:36 PM
Buten Matthew Chief Financial Officer Oct 03, 2022 Option Exercise $6.37 13,000 82,810 34,838 Oct 05, 2022, 05:36 PM
Bailey Gregory Director Oct 03, 2022 Option Exercise $7.50 11,975 89,813 1,307,971 Oct 05, 2022, 05:35 PM
Bailey Gregory Director Oct 03, 2022 Option Exercise $3.19 28,117 89,799 1,319,946 Oct 05, 2022, 05:35 PM
Coric Vlad Chief Executive Officer Oct 03, 2022 Option Exercise $7.50 115,940 869,550 1,037,729 Oct 05, 2022, 05:33 PM
Coric Vlad Chief Executive Officer Oct 03, 2022 Option Exercise $1.48 586,249 869,494 1,153,669 Oct 05, 2022, 05:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Coric Vlad Chief Executive Officer 10/31/2022 411,995
Coric Vlad Chief Executive Officer 10/28/2022 1,482,420
Coric Vlad Chief Executive Officer 10/28/2022 623,352
Bailey Gregory Director 10/25/2022 2,100,000
Coric Vlad Chief Executive Officer 10/25/2022 8,960,490
CHILDS JOHN W Director 10/25/2022 40,950,000
Buten Matthew Chief Financial Officer 10/25/2022 1,499,999
GREGORY JULIA P Director 10/25/2022 99,992
HUGIN ROBERT J Director 10/03/2022 97,193
Heffernan Michael Thomas Director 10/03/2022 72,743
Coric Vlad Chief Executive Officer 10/05/2022 2,502,096
Coric Vlad Chief Executive Officer 10/05/2022 2,507,329
CHILDS JOHN W Director 10/05/2022 2,461,172
Heffernan Michael Thomas Director 10/03/2022 41,303
Heffernan Michael Thomas Director 10/03/2022 72,729
Gentile Kimberly SVP, Clinical Operations 10/03/2022 262,444
Gentile Kimberly SVP, Clinical Operations 10/03/2022 281,160
Mehta Kishan Director 10/03/2022 82,012
Mehta Kishan Director 10/03/2022 87,860
GREGORY JULIA P Director 10/03/2022 89,813
GREGORY JULIA P Director 10/03/2022 89,799
CHILDS JOHN W Director 10/03/2022 41,303
CHILDS JOHN W Director 10/03/2022 41,289
HUGIN ROBERT J Director 10/03/2022 24,473
HUGIN ROBERT J Director 10/03/2022 73,406
Buten Matthew Chief Financial Officer 10/03/2022 82,815
Buten Matthew Chief Financial Officer 10/03/2022 82,810
Bailey Gregory Director 10/03/2022 89,813
Bailey Gregory Director 10/03/2022 89,799
Coric Vlad Chief Executive Officer 10/03/2022 869,550
Coric Vlad Chief Executive Officer 10/03/2022 869,494
Load More Insider Transactions